# Acute Glycemic and Insulinemic Response of FOSSENCE™

> **NCT03755232** · NA · COMPLETED · sponsor: **TATA CHEMICALS LTD** · enrollment: 25 (actual)

## Conditions studied

- Dietary Modification
- Healthy

## Interventions

- **DIETARY_SUPPLEMENT:** scFOS
- **OTHER:** Control

## Key facts

- **NCT ID:** NCT03755232
- **Lead sponsor:** TATA CHEMICALS LTD
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-12-06
- **Primary completion:** 2019-02-27
- **Final completion:** 2019-09-09
- **Target enrollment:** 25 (ACTUAL)
- **Last updated:** 2019-09-11

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03755232

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03755232, "Acute Glycemic and Insulinemic Response of FOSSENCE™". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03755232. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*